Charles Schwab Investment Management Inc Catalyst Biosciences, Inc. Transaction History

Charles Schwab Investment Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$3.78 - $5.18 $49,567 - $67,925	-13,113 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$4.1 - $5.33 $269,074 - $349,797	-65,628 Reduced 83.35%	13,113 $57,000
Q1 2021 May 17, 2021	BUY	$4.93 - $7.15 $135,570 - $196,617	27,499 Added 53.66%	78,741 $397,000
Q3 2020 Nov 13, 2020	BUY	$4.22 - $6.04 $33,371 - $47,764	7,908 Added 18.25%	51,242 $221,000
Q2 2020 Aug 14, 2020	BUY	$3.76 - $8.01 $162,935 - $347,105	43,334 New	43,334 $255,000
Q2 2019 Aug 09, 2019	SELL	$7.08 - $10.6 $196,930 - $294,839	-27,815 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$7.67 - $9.96 $43,834 - $56,921	5,715 Added 25.86%	27,815 $226,000
Q3 2018 Nov 13, 2018	SELL	$9.35 - $12.44 $31,116 - $41,400	-3,328 Reduced 13.09%	22,100 $239,000
Q2 2018 Aug 08, 2018	BUY	$9.11 - $28.88 $231,649 - $734,360	25,428 New	25,428 $297,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.